Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus
- 31 October 1991
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 14 (10) , 452-457
- https://doi.org/10.1016/0166-2236(91)90044-u
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune responseCell, 1991
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991
- Stiff‐man syndrome: A GABAergic autoimmune disorder with autoantigenic heterogeneityAnnals of Neurology, 1990
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man SyndromeNew England Journal of Medicine, 1990
- Molecular Identification of the 62 kd Form of Glutamic Acid Decarboxylase from the MouseEuropean Journal of Neuroscience, 1990
- Stiff-Man Syndrome — An Autoimmune Disease?New England Journal of Medicine, 1988
- Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes MellitusNew England Journal of Medicine, 1988
- Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Resolution of Stiff-Man Syndrome with Cortisol Replacement in a Patient with Deficiencies of ACTH, Growth Hormone, and ProlactinNew England Journal of Medicine, 1984